# Tranexamic Acid Dosing for Major Joint Replacement Surgery

> **NCT05075200** · PHASE2 · COMPLETED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 21 (actual)

## Conditions studied

- Arthroplasty, Replacement, Knee
- Arthroplasty, Replacement, Hip

## Interventions

- **DRUG:** Tranexamic acid

## Key facts

- **NCT ID:** NCT05075200
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-14
- **Primary completion:** 2022-10-26
- **Final completion:** 2022-10-26
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05075200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05075200, "Tranexamic Acid Dosing for Major Joint Replacement Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05075200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*